title: Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells.
abstract: Interleukin-6 (IL-6) has a complex spectrum of biological activities, for example, growth and differentiation of B cells and synthesis of acute-phase proteins by the liver. To evaluate the role of this cytokine in the inflammatory response induced by blood interaction with hemodialysis membranes, we have investigated the IL-6 synthesis and release in supernatant of 24-hour cultured peripheral blood mononuclear cells (PBMC) isolated from: (a) 10 hemodialyzed patients, (b) seven patients with advanced chronic renal failure (GFR less than or equal to 10 ml/min), and (c) eight healthy control subjects. In the same groups of subjects we evaluated the relationship between IL-6 synthesis and release and beta-2-microglobulin (beta 2m) production. Before and after dialytic treatment hemodialysis patient blood samples were drawn using the following criteria: (1) after two months of dialysis with cuprophan membranes, (2) after one and two months of dialysis with polymethylmethacrylate (PMMA) membranes, and finally, (3) after one further month of dialysis with cuprophan membranes. IL-6 was determined after 72 hours of incubation of PBMC supernatant serial dilutions with IL-6-dependent hybridoma cell line, 7TD1. Compared to IL-6 synthesis in control subjects (6.0 +/- 5.6 U/3 x 10(6) PBMC/24 hr), hemodialyzed patients, when treated with cuprophan membranes, showed significantly higher value of IL-6 production both before (23 +/- 13 U/3 x 10(6) PBMC/24 hr) and after (26.2 +/- 11.3 U/3 x 10(6) PBMC/24 hr) the dialytic session.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Nephrology, II Faculty of Medicine, University of Naples, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Memoli
authors.forename: C
authors.initials: C
authors.lastname: Libetta
authors.forename: T
authors.initials: T
authors.lastname: Rampino
authors.forename: A
authors.initials: A
authors.lastname: Dal Canton
authors.forename: G
authors.initials: G
authors.lastname: Conte
authors.forename: G
authors.initials: G
authors.lastname: Scala
authors.forename: M R
authors.initials: MR
authors.lastname: Ruocco
authors.forename: V E
authors.initials: VE
authors.lastname: Andreucci
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000209:etiology; D002482:Cellulose / Q000031:analogs & derivatives; D005260:Female; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D007688:Kidneys, Artificial; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D008297:Male; D008567:Membranes, Artificial; D008768:Methylmethacrylates; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*; D014511:Uremia / Q000097:blood / Q000276:immunology / Q000628:therapy; D001613:beta 2-Microglobulin / Q000096:biosynthesis
chemical_list: D015850:Interleukin-6; D008567:Membranes, Artificial; D008768:Methylmethacrylates; D001613:beta 2-Microglobulin; D002482:Cellulose; C009865:cuprammonium cellulose